Citations

Showing 10 of 108083 citations.

Clinical Features of a Family with Multiple Endocrine Neoplasia Type 2A Caused by the D631Y RET Mutation
Ospina, Naykky Singh , Maraka, Spyridoula , Donegan, Diane , Morris, John C., Maraka, Spyridoula , Singh Ospina, Naykky

Mayo Clinic

Thyroid® | July 27, 2017 | Volume: 27 | Issue: 10 | Pages: 1332-1334

10.1089/thy.2016.0536 | PMID 28747092 Get It

We describe a family with multiple endocrine neoplasia type 2A (MEN2A) caused by the D631Y RET mutation resulting in an atypical phenotype. The index case was a 24-year-old man with history of recurrent anaplastic ependymoma incidentally found to have the D631Y RET mutation. At first assessment, four family members had evidence of large pheochromocytomas. One patient was found to have micromedullary thyroid cancer at 79 years of age. None of the patients had primary hyperparathyroidism. Patients with MEN2A caused by a D631Y RET mutation most commonly present with pheochromocytomas. Medullary thyroid cancer is a less common part of the syndrome when compared with other RET mutations.
Dr Albert L. Rhoton Jr's Time at the Mayo Clinic: The Beginnings of a Remarkable Career
Rayan, Tarek, Carlson, Matthew L. , Piepgras, David G., Link, Michael J., Link, Michael J. , Gompel, Jamie J. Van

Mayo Clinic

Neurosurgery | July 26, 2017 | Volume: 83 | Issue: 2 | Pages: 297-308

10.1093/neuros/nyx428 | PMID 28945853 Get It

Abstract Dr Albert L. Rhoton Jr became the focal point of neurosurgery's evolution in understanding the intricate and complex microanatomy of the human brain over the last 4 decades. His pioneering work on cadaveric specimens proved to be a pivotal endeavor in the pursuit to better understand the complex microsurgical anatomy of cranial surgery. This paper details his early career at the Mayo Clinic in Rochester, Minnesota. A comprehensive review and synthesis of data acquired from the institutional historical archives including the Annual Reports to the Executive Committee, the Reports to the Board of Directors, the MAYOVOX Newsletter, the illustration archives of the Mayo Clinic Division of Creative Media, staff biographies, curriculum vitae, personal interviews, as well as full-text journal articles, and book publications was performed. Dr Rhoton was engaged in a busy clinical practice as a young staff at the Mayo Clinic. Records show he focused on tackling complex intracranial pathologies along with numerous basic research and neuroanatomy projects that became a major part of his life's work and passion. He was a great teacher and friend to countless individuals and his work will continue to impact and improve the care provided to neurosurgery patients for generations to come.
Spot urine protein measurements in normotensive pregnancies, pregnancies with isolated proteinuria and preeclampsia
Kattah, Andrea G. , Milić, Nataša , Kattah, Andrea, Garovic, Vesna, White, Wendy , Garovic, Vesna D. , Milic, N

Mayo Clinic

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology | July 26, 2017 | Volume: 313 | Issue: 4 | Pages: R418-R424

10.1152/ajpregu.00508.2016 | PMID 28747409 Get It

We performed a prospective, longitudinal study of pregnant women presenting to their first obstetrics visits to characterize the changes in spot urine protein-to-creatinine (UPCR) and albumin-to-creatinine ratios (UACR) in normotensive pregnancies, as well as identify clinical characteristics associated with isolated proteinuria and preeclampsia. We measured spot urinary albumin, protein, and creatinine at the first prenatal visit, end of the second trimester, and at delivery. In the normotensive pregnancies ( n = 142), we found that from the beginning of pregnancy to delivery, UACR increased by a median [interquartile range (IQR)] of 14.7 mg/g Cr (3.74–51.8) and UPCR by 60 mg/g Cr (30–130) ( P < 0.001 for both changes). Isolated proteinuria (defined as UPCR > 300 mg/g Cr in the absence of hypertension) was identified in 19/142 (13.4%) normotensive pregnancies. Increases in systolic and diastolic blood pressure from early pregnancy to delivery and increases in UACR from early to midpregnancy were associated with isolated proteinuria at delivery. Twelve women developed preeclampsia. Nulliparity, early, and midpregnancy diastolic blood pressures were strongly associated with the development of preeclampsia, but early changes in UACR were not. In conclusion, women who develop isolated proteinuria at delivery have a larger increase in blood pressure than women without proteinuria and have a “microalbuminuric” phase earlier in gestation, unlike women who develop preeclampsia. These findings suggest a different mechanism of urine protein excretion in women with isolated proteinuria as compared with women with preeclampsia, where proteinuria has a more abrupt onset.
Hepatotoxicity After Immune Checkpoint Inhibitor Therapy in Melanoma
Huffman, Brandon M. , Kottschade, Lisa A. , Kamath, Patrick S. , Markovic, Svetomir N.

Mayo Clinic

American Journal of Clinical Oncology | July 26, 2017 | Volume: 41 | Issue: 8 | Pages: 760-765

10.1097/coc.0000000000000374 | PMID 28749795 Get It

Objective: To report the clinical features, treatment, and outcomes of patients with immune checkpoint inhibitor-induced hepatotoxicity. Patients and Methods: In this retrospective observational study, we identified patients with metastatic malignant melanoma seen in consultation and/or treated between March 2011 and March 2016. Hepatotoxicity was assessed using the Common Terminology Criteria for Adverse Events, v4.0. Results: Seventeen patients were identified as having any degree of hepatotoxicity by history (grade 1 to 4). Twelve of 17 were diagnosed after ipilimumab, 3 of 17 were diagnosed after pembrolizumab, and 2 of 17 after ipilimumab combined with nivolumab. Median time from first dose of immune therapy to hepatotoxicity was 52 days. Clinical symptoms were variable: asymptomatic, fatigue, myalgias, headache, abdominal pain, nausea, vomiting, confusion, and/or jaundice. Eight patients had concurrent adverse events including colitis, hypophysitis, pneumonitis, and/or rash. Immune therapy was discontinued in all patients except 3. The patients were most commonly treated with systemic corticosteroids such as prednisone. Immunosuppression was discontinued by taper over a median of 42 days; in 3 patients steroids had to be reinitiated based on clinical or laboratory worsening of liver tests. Normalization of liver tests was seen within a median of 31 days of immunosuppression initiation. One patient with grade 4 hepatotoxicity had normalization with the addition of cyclosporine. Conclusions: Melanoma patients treated with immune checkpoint inhibitors should be monitored regularly for hepatotoxicity. Treatment with discontinuation of therapy and initiation of corticosteroids is indicated with grade 3 or 4 hepatotoxicity. Cyclosporine may be beneficial in steroid-refractory hepatotoxicity.
OxPL
Best, Patricia J.M. , Rajamannan, Nalini M.

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | July 26, 2017 | Volume: 37 | Issue: 8 | Pages: 1425-1427

10.1161/atvbaha.117.309719 | PMID 28747455 Get It

“Seek and you shall find” The Bible, Matthew 7:7
Werlang, Monia E., Francis, Dawn L., Wallace, Michael B. , Wallace, Michael B

Mayo Clinic

Endoscopy | July 26, 2017 | Volume: 49 | Issue: 08 | Pages: 729-731

10.1055/s-0043-110669 | PMID 28746963 Get It

Outcomes of patients with metastatic phaeochromocytoma and paraganglioma: A systematic review and meta‐analysis
Hamidi, Oksana , Gruber, Lucinda , Smestad, John , Yan, Qi , Ponce, Oscar J. , Murad, M. Hassan , Murad, Mohammad Hassan, Young, William F. , Prokop, Larry J. , Bancos, Irina , Murad, M Hassan , Hamidi, Oksana , Yan, Qi , Ponce, Oscar Josue , Smestad, John

Mayo Clinic

Clinical Endocrinology | July 26, 2017 | Volume: 87 | Issue: 5 | Pages: 440-450

10.1111/cen.13434 | PMID 28746746 Get It

Summary Objective The outcomes of patients with metastatic phaeochromocytoma (PHEO) and paraganglioma (PGL) are unclear. We performed a systematic review and meta‐analysis of baseline characteristics and mortality rates of patients with metastatic PHEO and PGL (PPGL). Design Ovid MEDLINE In‐Process & Other Non‐Indexed Citations, Ovid MEDLINE, Ovid EMBASE, Ovid Cochrane Central Register of Controlled Trials, Ovid Cochrane Database of Systematic Reviews, Scopus, Web of Science, and references of key articles were searched from inception to 2016. Patients Studies comprised ≥20 patients with metastatic PPGL and reported baseline characteristics and follow‐up data. Measurements Reviewers extracted standardized data and assessed risk of bias using a modified Newcastle‐Ottawa tool. Random‐effects meta‐analysis was used to pool event rates across studies. Results Twenty retrospective noncomparative studies reported on 1338 patients with metastatic PHEO (685/1296, 52.9%) and PGL (611/1296, 47.1%), diagnosed at a mean age of 43.9 ± 5.2 years. Mean follow‐up was 6.3 ± 3.2 years. Of 532 patients with reported data, 40.4% had synchronous metastases. Five‐year (7 studies, n = 738) and 10‐year (2 studies, n = 55) mortality rates for patients with metastatic PPGL were 37% (95% CI, 24%‐51%) and 29% (95% CI, 17%‐42%), respectively. Higher mortality was associated with male sex (RR 1.50; 95% CI, 1.11‐2.02) and synchronous metastases (RR 2.43; 95% CI, 1.01‐5.85). Conclusions Available low‐quality evidence from heterogeneous studies suggests low mortality rates of patients with metastatic PPGL. Male sex and synchronous metastases correlated with increased mortality. The outcomes of patients with metastatic PPGL have been inadequately assessed, indicating the need for carefully planned prospective studies.
Utility of Ipilimumab in Melanoma Patients who Progress on Anti-PD-1 Therapy
Ochoa, Cesar E. , Joseph, Richard W.

Mayo Clinic

Melanoma Management | July 26, 2017 | Volume: 4 | Issue: 3 | Pages: 143-145

10.2217/mmt-2017-0010 | PMID 30190917 Get It

Fatal Carney Complex in Siblings Due to De Novo Large Gene Deletion
Stelmachowska‐Banaś, Maria , Zgliczyński, Wojciech , Tutka, Piotr , Carney, J. Aidan, Korbonits, Márta

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | July 26, 2017 | Volume: 102 | Issue: 11 | Pages: 3924-3927

10.1210/jc.2017-01045 | PMID 28973408 Get It

Abstract Context Carney complex (CNC) is a rare multiple neoplasia syndrome involving cardiac, endocrine, neural, and cutaneous tumors and a variety of pigmented skin lesions. CNC can be inherited as an autosomal dominant trait, but in about one-third of patients, the disease is caused by de novo mutation in the PRKAR1A gene localized on chromosome 17q22-24. Most of the mutations include single base substitutions and small deletions/insertions not exceeding 15 base pairs. Recently, large germline PRKAR1A deletions have been described and may cause a more severe phenotype. Case Description Herein, we report the cases of two siblings with CNC with a de novo large deletion of 107 kb at 17q24.2 associated with acromegaly in both and primary pigmented nodular adrenocortical disease, cardiac myxoma, and lethal metastatic melanotic schwannian tumor at the age of 27 years in one of them, supporting the hypothesis that large deletions of PRKAR1A lead to severe disease. Conclusions To our knowledge, this is the first description of familial CNC in siblings in which neither parent carried the deletion in blood-derived DNA, suggesting that one of them had germ cell mosaicism for this deletion. Testing for large gene deletions should be obtained in all patients who meet the diagnostic criteria for CNC but do not have a PRKAR1A mutation by Sanger sequencing.
Culturing Periosteum in Vitro: The Influence of Different Sizes of Explants
Miura, Yasushi , O’Driscoll, Shawn W.

Mayo Clinic

Cell Transplantation | July 26, 2017 | Volume: 7 | Issue: 5 | Pages: 453-457

10.1177/096368979800700504 | PMID 9786065 Get It

Periosteal transplantation is being used clinically to repair articular defects. Isolated cells and very small periosteal explants can be grown in tissue culture, but it will be necessary to test larger sizes for tissue engineering to be applied to clinical transplantation of periosteum. This study was conducted to assess the chondrogenic potential of different sizes of periosteal explants in agarose culture. Ninety-six rabbit tibial periosteal explants in three different sizes (small 1.5 × 2, medium 3 × 2, and large 4 × 6 mm, 32 pieces per size) were cultured in agarose suspension for 6 wk and given TGF-β1 (10 ng/mL) for the first 2 wk. Tissue growth, as indicated by normalized final wet weights of the explants after 6 wk in culture, was inversely proportional to explant size. Cartilage formation was observed in all explante. Histomorphometry revealed that cartilage formation was significantly better for the smaller explants (80% cartilage), but similar in the medium and larger explants (60% cartilage). Similar proportions of type II collagen were present in the different-sized explants. This study demonstrates that various sizes of periosteal explants can be grown in culture. Abundant cartilage was produced even by the large explants. © 1998 Elsevier Science Inc.